| 1 |
30686534 | The release and activity of HMGB1 in ferroptosis. | 2019 Mar 5 |
1 |
| 2 |
28474222 | Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. | 2018 Jan |
3 |
| 3 |
28555325 | Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. | 2018 Jan |
1 |
| 4 |
30123419 | Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development. | 2018 Jul 24 |
1 |
| 5 |
29246127 | High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo. | 2017 Dec 15 |
14 |